Literature DB >> 32825953

The role of tumor-associated macrophages in the development, metastasis and treatment of breast cancer.

Jing Lu1, Li Ma2.   

Abstract

Tumor-associated macrophages (TAMs) play an important role in promoting cancer in the breast cancer microenvironment. A large number of preclinical studies have demonstrated that TAMs regulate related signaling pathways by releasing a variety of chemokines, affecting breast cancer growth, metastasis, and drug resistance. In recent years, TAMs have attracted much attention as potential biomarkers for breast cancer. This article reviews the preclinical evidence of the relationship between TAMs and the breast cancer microenvironment, the role of TAMs in prognosis, and the clinical outcomes related to targeted therapy.
Copyright © 2020 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Biomarker; Breast cancer; Targeted therapy; Tumor-associated macrophages

Mesh:

Substances:

Year:  2020        PMID: 32825953     DOI: 10.1016/j.prp.2020.153085

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  6 in total

Review 1.  Immune Infiltrates in Breast Cancer: Recent Updates and Clinical Implications.

Authors:  Maria Vittoria Dieci; Federica Miglietta; Valentina Guarneri
Journal:  Cells       Date:  2021-01-23       Impact factor: 6.600

Review 2.  The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer.

Authors:  Yiqi Fan; Shuai He
Journal:  Cancer Manag Res       Date:  2022-01-03       Impact factor: 3.989

3.  Identification of Differentially Expressed Hub Genes Associated With Immune Cell Recruitment in Claudin-Low Breast Cancer.

Authors:  Yange Wang; He Shi; Yulu Zhang; Qian Zeng; Tingmei Chen; Chengsen Chai
Journal:  Front Oncol       Date:  2022-03-11       Impact factor: 6.244

4.  One Ferroptosis-Related Gene-Pair Signature Serves as an Original Prognostic Biomarker in Lung Adenocarcinoma.

Authors:  Lei Li; Buhai Wang
Journal:  Front Genet       Date:  2022-03-16       Impact factor: 4.599

Review 5.  The Macrophage Response Is Driven by Mesenchymal Stem Cell-Mediated Metabolic Reprogramming.

Authors:  Noymar Luque-Campos; Felipe A Bustamante-Barrientos; Carolina Pradenas; Cynthia García; María Jesús Araya; Candice Bohaud; Rafael Contreras-López; Roberto Elizondo-Vega; Farida Djouad; Patricia Luz-Crawford; Ana María Vega-Letter
Journal:  Front Immunol       Date:  2021-06-04       Impact factor: 7.561

6.  M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer.

Authors:  Masanori Oshi; Yoshihisa Tokumaru; Mariko Asaoka; Li Yan; Vikas Satyananda; Ryusei Matsuyama; Nobuhisa Matsuhashi; Manabu Futamura; Takashi Ishikawa; Kazuhiro Yoshida; Itaru Endo; Kazuaki Takabe
Journal:  Sci Rep       Date:  2020-10-06       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.